- Dec 26, 2019
Krupa Rajur, MD, CEO & President of C2I Accelerator speaks about C2I's mission
Krupa Rajur, MD, founded C2I Accelerator with Raj Rajur, PhD, with a mission to foster the next generation of entrepreneurs and start-ups...
- Oct 17, 2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
IM Therapeutics is a clinical stage company developing personalized therapies for autoimmune disease. On October 9th, they announced that...
- Oct 16, 2019
Welcome IM Therapeutics to the C2I Family!
We would love to extend our warm welcome to IM Therapeutics! IM Therapeutics is redefining autoimmunity and transforming lives by...